Fluconazole new triazole antifungal agent Fluconazole fluorine-substituted bis-triazole antifungal agent mechanism action azoles interruption conversion lanosterol cytochrome subsequent disruption fungal membranes Activity Aspergillus Blastomyces dermatitidis Candida Coccidioides immitis Cryptococcus Histoplasma capsulatum Paracoccidioides brasiliensis several animal models Fluconazole Mean peak serum concentrations human volunteers mg oral mumols/L Protein binding low percent cerebrospinal fluid ratio Serum half-life long hours elimination renal clearance unchanged drug Clinical trials reports support use fluconazole treatment candidiasis oropharyngeal esophageal infections immunocompromised hosts Fluconazole initial suppressive therapy cryptococcal meningitis role management systemic fungal infections results comparative trials available Fluconazole effects steroidogenesis ketoconazole Antipyrine clearance low doses mg fluconazole drug interactions use doses agents cyclosporin phenytoin oral hypoglycemics warfarin Rifampin metabolic clearance fluconazole Fluconazole available oral parenteral formulations Once-daily doses mg Dosage reduction patients impaired renal function 